Elspeth Carnan, Ph.D. serves as Alkermes’ Senior Vice President of Clinical Operations. In this role, Dr. Carnan leads the clinical trial management, clinical supply chain, data management and study start-up functions. She is responsible for the execution of all clinical programs supporting Clinical Development at Alkermes.
Dr. Carnan has more than 30 years of global clinical program and portfolio management experience in preclinical and clinical stage programs across a variety of therapeutic areas. Prior to joining Alkermes, she served as the Vice President, Global Head of Clinical Trial Management and Global Monitoring at Regeneron. Earlier in her career, Dr. Carnan held various leadership positions at EMD Serono, Sunovion Pharmaceuticals, Amgen and GlaxoSmithKline.
Dr. Carnan received a bachelor’s degree in Physiology from the University of Glasgow and a Ph.D. in Physiology from the University of Newcastle Medical School in England.